Pityriasis rubra pilaris (type I) following administration of the BNT162b2 mRNA COVID ‐19 vaccine: successful treatment with Ustekinumab and acitretin

Dermatologic Therapy(2022)

引用 1|浏览1
暂无评分
摘要
Dermatologic TherapyVolume 35, Issue 12 e15899 LETTER Pityriasis rubra pilaris (type I) following administration of the BNT162b2 mRNA COVID-19 vaccine: Successful treatment with ustekinumab and acitretin Shirley Braga Lima Gamonal, Corresponding Author Shirley Braga Lima Gamonal [email protected] orcid.org/0000-0003-1575-5214 Department of Dermatology, Faculty of Medicine, Federal University of Juiz de Fora (UFJF), Juiz de Fora, Brazil Correspondence Shirley Braga Lima Gamonal, Núcleo de Pesquisa em Dermatologia (NUPEDE), Universidade Federal de Juiz de Fora (UFJF), Juiz de Fora (MG), Brazil. Email: [email protected]Search for more papers by this authorNathália Couri Vieira Marques, Nathália Couri Vieira Marques orcid.org/0000-0001-6310-0111 Faculty of Medicine, Federal University of Juiz de Fora (UFJF), Juiz de Fora, BrazilSearch for more papers by this authorHeitor Motta Bini Pereira, Heitor Motta Bini Pereira orcid.org/0000-0001-9845-4876 Department of Dermatology, School of Medical Sciences and Health of Juiz de Fora (FCMS/JF), Juiz de Fora, BrazilSearch for more papers by this authorAloisio Carlos Couri Gamonal, Aloisio Carlos Couri Gamonal orcid.org/0000-0002-5893-8283 Department of Dermatology, Faculty of Medicine, Federal University of Juiz de Fora (UFJF), Juiz de Fora, BrazilSearch for more papers by this author Shirley Braga Lima Gamonal, Corresponding Author Shirley Braga Lima Gamonal [email protected] orcid.org/0000-0003-1575-5214 Department of Dermatology, Faculty of Medicine, Federal University of Juiz de Fora (UFJF), Juiz de Fora, Brazil Correspondence Shirley Braga Lima Gamonal, Núcleo de Pesquisa em Dermatologia (NUPEDE), Universidade Federal de Juiz de Fora (UFJF), Juiz de Fora (MG), Brazil. Email: [email protected]Search for more papers by this authorNathália Couri Vieira Marques, Nathália Couri Vieira Marques orcid.org/0000-0001-6310-0111 Faculty of Medicine, Federal University of Juiz de Fora (UFJF), Juiz de Fora, BrazilSearch for more papers by this authorHeitor Motta Bini Pereira, Heitor Motta Bini Pereira orcid.org/0000-0001-9845-4876 Department of Dermatology, School of Medical Sciences and Health of Juiz de Fora (FCMS/JF), Juiz de Fora, BrazilSearch for more papers by this authorAloisio Carlos Couri Gamonal, Aloisio Carlos Couri Gamonal orcid.org/0000-0002-5893-8283 Department of Dermatology, Faculty of Medicine, Federal University of Juiz de Fora (UFJF), Juiz de Fora, BrazilSearch for more papers by this author First published: 05 October 2022 https://doi.org/10.1111/dth.15899Citations: 1Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL No abstract is available for this article.Citing Literature Volume35, Issue12December 2022e15899 RelatedInformation
更多
查看译文
关键词
Interleukin,Pityriasis rubra pilaris,SARS-CoV-2,Systemic therapy,Vaccine
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要